Jane Street Group, LLC Rhythm Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 109,186 shares of RYTM stock, worth $6.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

109,186

Previous 146,500 25.47%

Holding current value

$6.24 Million

Previous $6.02 Million 4.9%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.81 - $55.0 $1.52 Million - $2.05 Million	-37,314 Reduced 25.47%	109,186 $5.72 Million
Q2 2024 Aug 14, 2024	BUY	$35.41 - $44.37 $4.26 Million - $5.33 Million	120,182 Added 456.65%	146,500 $6.02 Million
Q1 2024 May 15, 2024	SELL	$39.12 - $52.44 $6.18 Million - $8.29 Million	-158,041 Reduced 85.72%	26,318 $1.14 Million
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $863,236 - $2 Million	40,357 Added 28.03%	184,359 $8.47 Million
Q3 2023 Nov 14, 2023	BUY	$15.81 - $27.8 $1.07 Million - $1.89 Million	67,978 Added 89.42%	144,002 $3.3 Million
Q2 2023 Aug 14, 2023	SELL	$16.32 - $21.15 $4.47 Million - $5.79 Million	-273,615 Reduced 78.26%	76,024 $1.25 Million
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $2.53 Million - $5.14 Million	150,136 Added 75.26%	349,639 $6.24 Million
Q4 2022 Feb 14, 2023	BUY	$22.21 - $30.25 $4.43 Million - $6.03 Million	199,503 New	199,503 $5.81 Million
Q2 2022 Aug 16, 2022	SELL	$3.12 - $12.25 $59,039 - $231,806	-18,923 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$6.13 - $12.24 $115,997 - $231,617	18,923 New	18,923 $218,000
Q2 2021 Aug 16, 2021	SELL	$18.52 - $22.55 $217,980 - $265,413	-11,770 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$20.25 - $39.49 $59,373 - $115,784	2,932 Added 33.17%	11,770 $251,000
Q4 2020 Feb 17, 2021	BUY	$21.17 - $32.61 $187,100 - $288,207	8,838 New	8,838 $263,000
Q3 2020 Nov 17, 2020	SELL	$18.13 - $30.61 $172,325 - $290,948	-9,505 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$14.41 - $25.35 $36,255 - $63,780	-2,516 Reduced 20.93%	9,505 $212,000
Q1 2020 May 15, 2020	BUY	$13.16 - $22.9 $158,196 - $275,280	12,021 New	12,021 $183,000
Q3 2018 Nov 14, 2018	SELL	$26.99 - $35.85 $325,391 - $432,207	-12,056 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$17.02 - $35.2 $205,193 - $424,371	12,056 New	12,056 $377,000

Others Institutions Holding RYTM

# of Institutions

189

Shares Held

67.1M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.18B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Rhythm Pharmaceuticals, Inc. Transaction History